Ventas, Inc. $VTR Shares Acquired by Hudson Bay Capital Management LP

Hudson Bay Capital Management LP boosted its holdings in Ventas, Inc. (NYSE:VTR) by 50.8% in the 3rd quarter, Holdings Channel reports. The firm owned 419,484 shares of the real estate investment trust’s stock after purchasing an additional 141,291 shares during the period. Hudson Bay Capital Management LP’s holdings in Ventas were worth $29,360,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently bought and sold shares of the company. Arbor Capital Management Inc. ADV increased its stake in Ventas by 0.6% in the third quarter. Arbor Capital Management Inc. ADV now owns 21,716 shares of the real estate investment trust’s stock valued at $1,520,000 after purchasing an additional 137 shares during the period. Foundations Investment Advisors LLC boosted its stake in shares of Ventas by 3.3% during the third quarter. Foundations Investment Advisors LLC now owns 4,447 shares of the real estate investment trust’s stock worth $311,000 after buying an additional 144 shares during the period. Ameritas Investment Partners Inc. lifted its position in Ventas by 3.8% during the 2nd quarter. Ameritas Investment Partners Inc. now owns 4,260 shares of the real estate investment trust’s stock worth $269,000 after acquiring an additional 155 shares during the period. Checchi Capital Advisers LLC increased its stake in Ventas by 3.9% in the 3rd quarter. Checchi Capital Advisers LLC now owns 4,603 shares of the real estate investment trust’s stock valued at $322,000 after buying an additional 174 shares during the period. Finally, Parallel Advisors LLC raised its holdings in Ventas by 4.6% during the third quarter. Parallel Advisors LLC now owns 3,970 shares of the real estate investment trust’s stock worth $278,000 after purchasing an additional 175 shares in the last quarter. Institutional investors and hedge funds own 94.18% of the company’s stock.

Insider Transactions at Ventas

In related news, CEO Debra A. Cafaro sold 10,322 shares of Ventas stock in a transaction dated Monday, February 2nd. The stock was sold at an average price of $77.66, for a total transaction of $801,606.52. Following the completion of the sale, the chief executive officer owned 1,114,034 shares in the company, valued at approximately $86,515,880.44. This trade represents a 0.92% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Carey S. Roberts sold 35,532 shares of Ventas stock in a transaction dated Wednesday, February 11th. The stock was sold at an average price of $85.00, for a total value of $3,020,220.00. Following the sale, the executive vice president owned 72,755 shares of the company’s stock, valued at approximately $6,184,175. This represents a 32.81% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 86,106 shares of company stock valued at $6,931,397 over the last three months. 0.80% of the stock is currently owned by insiders.

Analyst Ratings Changes

A number of brokerages recently weighed in on VTR. Argus set a $88.00 price objective on Ventas in a report on Tuesday, February 10th. Weiss Ratings raised shares of Ventas from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Monday, December 29th. KeyCorp raised their price objective on shares of Ventas from $85.00 to $90.00 and gave the company an “overweight” rating in a research note on Tuesday, February 10th. UBS Group reissued a “neutral” rating and set a $85.00 price objective on shares of Ventas in a report on Monday, February 9th. Finally, Morgan Stanley set a $90.00 target price on shares of Ventas in a report on Friday, February 13th. Thirteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat, Ventas currently has a consensus rating of “Moderate Buy” and a consensus price target of $89.00.

Ventas Stock Down 0.8%

Shares of NYSE VTR opened at $87.28 on Thursday. The firm’s 50-day moving average is $82.15 and its two-hundred day moving average is $76.80. The company has a market capitalization of $41.45 billion, a PE ratio of 161.63, a price-to-earnings-growth ratio of 2.17 and a beta of 0.73. Ventas, Inc. has a 12-month low of $60.15 and a 12-month high of $88.37. The company has a debt-to-equity ratio of 1.03, a current ratio of 0.67 and a quick ratio of 0.67.

Ventas (NYSE:VTR) last issued its quarterly earnings data on Thursday, February 5th. The real estate investment trust reported $0.15 earnings per share for the quarter, missing analysts’ consensus estimates of $0.89 by ($0.74). Ventas had a return on equity of 2.09% and a net margin of 4.31%.The business had revenue of ($1,229.71) million for the quarter, compared to analysts’ expectations of $1.53 billion. During the same period last year, the business earned $0.81 earnings per share. The company’s revenue for the quarter was up 21.7% on a year-over-year basis. Ventas has set its FY 2026 guidance at 3.780-3.880 EPS. Equities analysts anticipate that Ventas, Inc. will post 3.4 EPS for the current fiscal year.

Ventas Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, April 16th. Stockholders of record on Tuesday, March 31st will be issued a $0.52 dividend. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.4%. This is a positive change from Ventas’s previous quarterly dividend of $0.48. The ex-dividend date of this dividend is Tuesday, March 31st. Ventas’s payout ratio is presently 355.56%.

Ventas Company Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.